SCHEMBL9768629

SCHEMBL9768629

CCC(Cl)(Br)C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 10/20 0.47
CES2 O00748 7/20 0.44
SRC P12931 1/20 0.43
ALDH1A1 P00352 3/20 0.42
GSK3B P49841 2/20 0.42
MAPK1 P28482 2/20 0.42
TRPA1 O75762 1/20 0.42
HIF1A Q16665 1/20 0.42
PTPN1 P18031 1/20 0.42
CTNNB1 P35222 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9720587 0.82 CES1 (0.48) CES1CES2SRCALDH1A1GSK3B
SCHEMBL28327257 0.79 CES1 (0.50) CES1CES2SRCALDH1A1GSK3B
SCHEMBL18982981 0.79 CES1 (0.50) CES1CES2SRCALDH1A1GSK3B
SCHEMBL2292151 0.78 CES1 (0.45) CES1CES2SRCALDH1A1GSK3B
SCHEMBL11172533 0.78 CES1 (0.41) CES1CES2SRCALDH1A1GSK3B
SCHEMBL5031584 0.77 CES1 (0.52) CES1CES2SRCALDH1A1GSK3B
SCHEMBL8459655 0.77 CTNNB1 (0.61) CES1CES2SRCALDH1A1GSK3B
SCHEMBL11308508 0.77 CES1 (0.52) CES1CES2SRCALDH1A1GSK3B
SCHEMBL27714041 0.77 CES1 (0.52) CES1CES2SRCALDH1A1GSK3B
SCHEMBL1874832 0.76 CES1 (0.56) CES1CES2SRCALDH1A1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5059601-A IMIDAZOLONE DERIVATIVES WITH ACTIVITY ON CENTRAL NERVOUS SYSTEM AND ANTIHYPERTENSIVE ACTIVITY, PREPARATION METHODS THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ISTITUTO LUSOFARMACO D'ITALIA S.P.A. (IT) 1991-10-22 US disclosed